US 11739297
Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor
granted A61KA61K2239/13A61K2239/21
Quick answer
US patent 11739297 (Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor) held by Carisma Therapeutics Inc. expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Carisma Therapeutics Inc.
- Grant date
- Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2239/13, A61K2239/21, A61K2239/22, A61K38/00